Print

InVivo Therapeutics Corporation (NVIV) Neurosurgeon Receives MDHonors Grant for Applying Hydrogels to Spinal Cord Injury  
8/13/2012 9:15:25 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma, announced today that one of the company’s neurosurgeons, Amer Khalil, MD, has been selected as the winner of an MDH Research Award, a grant given by MDHonors, to further InVivo’s research on spinal cord injury.